000			02025 a2200625 4500
005			20250516163750.0
264		0	_c20140703
008			201407s 0 0 eng d
022			_a1476-5403
024	7		_a10.1038/cdd.2013.105 _2doi
040			_aNLM _beng _cNLM
100	1		_aJemaà, M
245	0	0	_aCharacterization of novel MPS1 inhibitors with preclinical anticancer activity. _h[electronic resource]
260			_bCell death and differentiation _cNov 2013
300			_a1532-45 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Cycle Proteins _xantagonists & inhibitors
650	0	4	_aDrug Synergism
650	0	4	_aFemale
650	0	4	_aHeLa Cells
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aRandom Allocation
650	0	4	_aTransfection
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aGalluzzi, L
700	1		_aKepp, O
700	1		_aSenovilla, L
700	1		_aBrands, M
700	1		_aBoemer, U
700	1		_aKoppitz, M
700	1		_aLienau, P
700	1		_aPrechtl, S
700	1		_aSchulze, V
700	1		_aSiemeister, G
700	1		_aWengner, A M
700	1		_aMumberg, D
700	1		_aZiegelbauer, K
700	1		_aAbrieu, A
700	1		_aCastedo, M
700	1		_aVitale, I
700	1		_aKroemer, G
773	0		_tCell death and differentiation _gvol. 20 _gno. 11 _gp. 1532-45
856	4	0	_uhttps://doi.org/10.1038/cdd.2013.105 _zAvailable from publisher's website
999			_c22993259 _d22993259